Multicenter evaluation of ceftolozane/tazobactam for serious infections caused by carbapenem-resistant pseudomonas aeruginosa

A multicenter, retrospective study of patients infected with carbapenem-resistant Pseudomonas aeruginosa who were treated with ceftolozane/tazobactam was performed. Among 35 patients, pneumonia was the most common indication and treatment was successful in 26 (74%). Treatment failure was observed in...

Full description

Autores:

Munita, Jose M.
Aitken, Samuel L.
Miller, William R.
Perez, Federico
Rosa, Rossana
Shimose, Luis A.
Lichtenberger, Paola N.
Abbo, Lilian M.
Jain, Rupali
Nigo, Masayuki
Wanger, Audrey
Araos, Rafael
Tran, Truc T.
Adachi, Javier
Rakita, Robert
Shelburne, Samuel
Bonomo, Robert A.
Arias, Cesar A.

Tipo de recurso:

Article of journal

Fecha de publicación:

2020

Institución:

Universidad El Bosque

Repositorio:

Repositorio U. El Bosque

Idioma:

eng

OAI Identifier:

oai:repositorio.unbosque.edu.co:20.500.12495/3679

Acceso en línea:

http://hdl.handle.net/20.500.12495/3679
https://doi.org/10.1093/cid/cix014
https://repositorio.unbosque.edu.co

Palabra clave:

Ceftolozane
Carbapenem resistant
P. aeruginosa
Multidrug resistant

Rights

openAccess

License

Acceso abierto